Pharma
33 brands
Data as of 1 Oct 2026
Markdown version
Markdown version
The three most-covered Pharma brands carried 33% of the sector's 815 catalog mentions over the last 12 months.
Share of voice · 12m (area = mentions, colour = sentiment)
| Brand | Mentions | Share | Avg sentiment | PR |
|---|---|---|---|---|
| Eli lilly | 130 | 16% | +0.363 | 7% |
| Astrazeneca | 78 | 10% | +0.153 | 6% |
| Pfizer | 64 | 8% | +0.085 | 2% |
| Johnson & johnson | 59 | 7% | +0.435 | 2% |
| Novo nordisk | 46 | 6% | +0.124 | 15% |
| Merck | 44 | 5% | +0.520 | 5% |
| Sandoz | 41 | 5% | +0.272 | 7% |
| Moderna | 38 | 5% | +0.615 | 3% |
| Bayer | 36 | 4% | +0.203 | 14% |
| Roche | 36 | 4% | +0.236 | 8% |
| Novartis | 36 | 4% | +0.190 | 0% |
| Egis | 35 | 4% | +0.404 | 20% |
| Lilly | 23 | 3% | +0.035 | 4% |
| J&j | 21 | 3% | +0.014 | 0% |
| Well Pharmacy | 20 | 2% | +0.381 | 0% |
| Abbott | 19 | 2% | +0.000 | 0% |
| Polpharma | 15 | 2% | +0.064 | 0% |
| Sanofi | 13 | 2% | +0.355 | 15% |
| Biontech | 10 | 1% | -0.370 | 0% |
| Krka | 8 | 1% | 0% | |
| ProCare | 7 | 1% | 29% | |
| Dr. Max | 7 | 1% | 0% | |
| Gsk | 6 | 1% | 50% | |
| Boehringer | 5 | 1% | 20% | |
| Abbvie | 3 | 0% | 0% | |
| Fresenius | 2 | 0% | 50% | |
| Medtronic | 2 | 0% | 50% | |
| Zentiva | 2 | 0% | 0% | |
| Adamed | 2 | 0% | 0% | |
| Gedeon Richter | 2 | 0% | 0% | |
| Pliva | 2 | 0% | 0% | |
| Farmacias del Ahorro | 2 | 0% | 0% | |
| Siemens healthineers | 1 | 0% | 100% |